相关实验视频
Updated: Sep 15, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
343
循环胺治疗无情的斑块性胆管炎的临床结果:描述性的病例系列
Miguel Pedroza-Seres1, Carlos E Rodríguez-López2
1Department of Uveitis and Ocular Immunology, Instituto de Oftalmología FAP Conde de Valenciana, Mexico City, Mexico.
Indian journal of ophthalmology
|July 18, 2025
概括
静脉注射环胺在治疗无情的斑块性胆管炎 (RPC) 方面表现有前途. 这项研究发现,RPC患者的视力明显改善,这种治疗的副作用最小.
科学领域:
- 眼科医生 眼科 眼科
- 免疫抑制疗法 免疫抑制疗法
背景情况:
- 无情的斑块性胆管炎 (RPC) 是一种罕见的眼部疾病,病因不明.
- 它呈现出一个长期的,渐进的过程和广泛的病变.
- 目前对RPC的治疗策略缺乏共识,而环胺的使用也没有得到充分的记录.
研究的目的:
- 评估无情的斑块性胆管炎 (RPC) 的临床表现和视觉结果.
- 在RPC患者中评估静脉注射环胺的疗效和安全性.
- 探索这种罕见疾病的新型治疗方法.
主要方法:
- 一个由四名被诊断患有无情的斑块性胆管炎 (RPC) 的患者组成的病例系列.
- 治疗包括注射静脉循环胺.
- 视力敏度和副作用受到监测.
主要成果:
- 从20/125到20/32观察到最佳校正视敏度 (BCVA) 的显著改善.
- 静脉注射环胺的治疗与最小的不良反应有关.
- 观察到的结果表明,对免疫抑制疗法有积极的反应.
结论:
- 静脉注射环胺在患有无情的斑块性胆管炎 (RPC) 的患者中表现出良好的结果.
- 这种治疗可能是RPC的安全,有效和经济高效的选择.
- 需要进一步的研究,以在更大的队列中证实这些发现.
相关概念视频
Open Angle Glaucoma: Treatment
577
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
577
Angle Closure Glaucoma: Treatment
691
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
691
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Chronic Kidney Disease II: Clinical Manifestations
101
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
101

